| 136661-100MG |
|
31989-10-3 |
(η5-?2,?4-Cyclopentadien-?1-?yl)?[(1,?2,?3,?3a,?8a-?η)?-?(8aR)?-?1,?8-?dihydro-?8-?oxocyclopent[a]?inden-?1-?yl]?iron
≥98%,98%e.e.
|
100MG |
C17H12FeO |
|
|
|
| 136651-100MG |
|
1809190-02-0 |
(η5-?2,?4-Cyclopentadien-?1-?yl)?[(5a,?6,?7,?8,?8a-?η)?-?(5aS)?-?5-?oxopentaleno[1,?2-?b]?pyridin-?5a(5H)?-?yl]?iron
≥95%,99%e.e.
|
100MG |
C16H11FeNO |
|
|
|
| 134978-1G |
|
NA |
(S)-N,N-Dimethyl-1-ferrocenylethylamine Tartrate
≥98%,98%e.e.
|
1G |
C14H19FeN·C4H6O6 |
|
|
|
| 134978-250MG |
|
NA |
(S)-N,N-Dimethyl-1-ferrocenylethylamine Tartrate
≥98%,98%e.e.
|
250MG |
C14H19FeN·C4H6O6 |
|
|
|
| 134977-1G |
|
NA |
(R)-N,N-Dimethyl-1-ferrocenylethylamine Tartrate
≥98%,99%e.e.
|
1G |
C14H19FeN·C4H6O6 |
|
|
|
| 134977-250MG |
|
NA |
(R)-N,N-Dimethyl-1-ferrocenylethylamine Tartrate
≥98%,99%e.e.
|
250MG |
C14H19FeN·C4H6O6 |
|
|
|
| 200005-500MG |
|
184095-69-0 |
(2R)?-1-?[(1R)?-?1-?[Bis(3,5-?dimethylphenyl)?phosphino]?ethyl]?-?2-?(diphenylphosphino)?ferrocene
≥98%,99%e.e.
|
500MG |
C40H40FeP2 |
|
|
|
| 200005-100MG |
|
184095-69-0 |
(2R)?-1-?[(1R)?-?1-?[Bis(3,5-?dimethylphenyl)?phosphino]?ethyl]?-?2-?(diphenylphosphino)?ferrocene
≥98%,99%e.e.
|
100MG |
C40H40FeP2 |
|
|
|
| 136034-100MG |
|
155941-31-4 |
(1S)-1-(Diphenylphosphino)-2-[(1R)-1-(diphenylphosphino)ethyl]ferrocene
≥98%,-
|
100MG |
C36H32FeP2 |
|
|
|
| 136035-100MG |
|
853336-96-6 |
(1R)-1-(Diphenylphosphino)-2-[(1S)-1-(diphenylphosphino)ethyl]ferrocene
≥98%,-
|
100MG |
C36H32FeP2 |
|
|
|
| 136033-100MG |
|
74311-54-9 |
(2S)-1-[(1R)-1-(Dimethylamino)ethyl]-2-(diphenylphosphino)ferrocene
≥98%,99%e.e.
|
100MG |
C26H28FeNP |
|
|
|
| 136007-100MG |
|
55650-58-3 |
(2R)-1-[(1S)-1-(Dimethylamino)ethyl]-2-(diphenylphosphino)ferrocene
≥98%,99%e.e.
|
100MG |
C26H28FeNP |
|
|
|
| 135078-1G |
|
162157-05-3 |
[(4S)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
1G |
C20H19FeNO |
|
|
|
| 135078-500MG |
|
162157-05-3 |
[(4S)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
500MG |
C20H19FeNO |
|
|
|
| 135079-1G |
|
NA |
[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
1G |
C20H19FeNO |
|
|
|
| 135079-500MG |
|
NA |
[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
500MG |
C20H19FeNO |
|
|
|
| 135076-1G |
|
162157-04-2 |
[(4S)-4,5-Dihydro-4-phenyl-2-oxazolyl]ferrocene
≥98%,-
|
1G |
C19H17FeNO |
|
|
|
| 135076-500MG |
|
162157-04-2 |
[(4S)-4,5-Dihydro-4-phenyl-2-oxazolyl]ferrocene
≥98%,-
|
500MG |
C19H17FeNO |
|
|
|
| 135077-1G |
|
215818-63-6 |
[(4R)-4,5-Dihydro-4-phenyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
1G |
C19H17FeNO |
|
|
|
| 135077-500MG |
|
215818-63-6 |
[(4R)-4,5-Dihydro-4-phenyl-2-oxazolyl]ferrocene
≥98%,99%e.e.
|
500MG |
C19H17FeNO |
|
|
|
